Distribution of 76Br-labeled antisense oligonucleotides of different length determined ex vivo in rats

被引:31
作者
Wu, F
Yngve, U
Hedberg, E
Honda, M
Lu, L
Eriksson, B
Watanabe, Y
Bergström, M [1 ]
Längström, B
机构
[1] Uppsala Univ, PET Ctr, Uppsala, Sweden
[2] Univ Uppsala Hosp, Dept Med, Uppsala, Sweden
[3] Uppsala Univ, Dept Organ Chem, Uppsala, Sweden
[4] Osaka Biosci Inst, Osaka, Japan
[5] Osaka City Univ, Osaka 558, Japan
关键词
antisense oligonucleotides; autoradiography; distribution in vivo; chromogranin A; positron emission tomography (PET); Br-76;
D O I
10.1016/S0928-0987(00)00067-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Oligonucleotides may hybridize with high selectivity to an RNA sequence and can be used for the monitoring of gene expression or for its inhibition in experimental or therapeutic purposes. As part of the development of positron emission tomography (PET) methods, different lengths (30, 20, 12 and 6 mer) of antisense phosphorothioate oligonucleotides complementary to rat chromogranin A were labeled with [Br-76] using a prosthetic group. The Br-76-oligonucleotides were injected into rat's tail vein (1-2 MBq/rat), and the radioactivity distribution was analyzed after 20 h using whole body autoradiography or by measurement of organ radioactivity concentration. The whole body autoradiography showed different distribution depending on the oligonucleotide length. The organs with highest uptake changed from kidney cortex (with 6 or 12 mer), kidney cortex and liver (with 20 mer), to liver and spleen (with 30 mer). With 20 or 30 mer sequences, uptake could be observed in the adrenals. Kidneys and livers from rats receiving 20 mer or 30 mer Br-76-oligonucleotides were analyzed with respect to subcellular distribution and DNA/RNA/protein fraction. 30%-45% of the radioactivity was found in the nuclear fraction. More than 80% of the radioactivity was recovered in the high molecular weight fraction (as proteins or oligonucleotides longer than 10 mer) using size exclusion (NAP 5) gelfiltration or cetylpyridinium bromide (CPB) precipitation. This work indicates the potential to perform kinetic whole body studies of Br-76-oligonucleotides using PET. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:179 / 186
页数:8
相关论文
共 25 条
[1]   Toxicologic effects of an oligodeoxynucleotide phosphorothioate and its analogs following intravenous administration in rats [J].
Agrawal, S ;
Zhao, QY ;
Jiang, ZW ;
Oliver, C ;
Giles, H ;
Heath, J ;
Serota, D .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1997, 7 (06) :575-584
[2]   Mixed-backbone oligonucleotides as second generation antisense oligonucleotides: In vitro and in vivo studies [J].
Agrawal, S ;
Jiang, ZW ;
Zhao, QY ;
Shaw, D ;
Cai, QY ;
Roskey, A ;
Channavajjala, L ;
Saxinger, C ;
Zhang, RW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) :2620-2625
[3]   Perspectives in antisense therapeutics [J].
Agrawal, S ;
Iyer, RP .
PHARMACOLOGY & THERAPEUTICS, 1997, 76 (1-3) :151-160
[4]  
Amado Rafael G., 1999, Frontiers in Bioscience, V4, pD468, DOI 10.2741/Amado
[5]  
Bilsky EJ, 1996, J PHARMACOL EXP THER, V277, P491
[6]   Distribution of the cellular uptake of phosphorothioate oligodeoxynucleotides in the rat kidney in vivo [J].
Carome, MA ;
Kang, YH ;
Bohen, EM ;
Nicholson, DE ;
Carr, FE ;
Kiandoli, LC ;
Brummel, SE ;
Yuan, CM .
NEPHRON, 1997, 75 (01) :82-87
[7]  
Crooke ST, 1996, J PHARMACOL EXP THER, V277, P923
[8]   WHOLE-BODY AUTORADIOGRAPHY USING C-11 WITH DOUBLE-TRACER APPLICATIONS [J].
DARGY, R ;
ULLBERG, S ;
STALNACKE, CG ;
LANGSTROM, B .
INTERNATIONAL JOURNAL OF APPLIED RADIATION AND ISOTOPES, 1984, 35 (02) :129-134
[9]   Antisense oligodeoxynucleotide treatment to the brain cannabinoid receptor inhibits antinociception [J].
Edsall, SA ;
Knapp, RJ ;
Vanderah, TW ;
Roeske, WR ;
Consroe, P ;
Yamamura, HI .
NEUROREPORT, 1996, 7 (02) :593-596
[10]   Treatment of rheumatoid arthritis with IL-1 inhibitors [J].
Gabay, C ;
Arend, WP .
SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1998, 20 (1-2) :229-246